"Questions considered: 1. What is the optimal chemotherapy for patients with multiple myeloma? 2. In terms of survival, is peripheral blood stem cell or autologous bone marrow transplantation better than conventional chemotherapy? 3. What is the relative efficacy of autologous and allogeneic transplantation? 4. What specifics of the transplant manoeuvre can be recommended? 5. When should transplantation be performed? 6. Who should (should not) be transplanted?"--Page iv-v.
- Pages
- 55
- Published in
- Ottawa, Ontario
